Merck inks deal worth up to $2.7 B with Chinese biotech startup LaNova Medicines
China | News | 0 Comment | 18 Nov, 2024
Merck, known as MSD outside of the United States and Canada, and China-based biotech startup LaNova Medicines, have anno...Read more
Terumo Blood and Cell Technologies unlocks new chapter of localisation in China
China | News | 0 Comment | 15 Nov, 2024
Terumo Blood and Cell Technologies (Terumo BCT), recently held a localisation launch ceremony themed 'Unlocking a ...Read more
Chime Biologics and Waterstone team up to empower ADC development and manufacturing
China | News | 0 Comment | 13 Nov, 2024
China-based Chime Biologics, a leading global contract development and manufacturing organisation (CDMO) that enables it...Read more
Novotech and Biostar establish strategic partnership following Biostar’s HKEX listing
China | News | 0 Comment | 12 Nov, 2024
Novotech, the global full-service clinical Contract Research Organisation (CRO) that partners with biotech companies to ...Read more
Ping An Health and Medtronic form strategic partnership
China | News | 0 Comment | 11 Nov, 2024
China-based Ping An Healthcare and Technology has established a strategic partnership with Medtronic (Shanghai) Man...Read more
Trump’s Trade Tango Returns: Will China’s Biotech Dance Through Another Round of Tariffs or Stumble?
China | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 09 Nov, 2024
With Donald Trump’s return to the White House, the U.S.-China trade relationship is once again in the spotlight. T...Read more
Hong Kong-based Insilico Medicine enters into revolving loan facility of up to $100 M with HSBC
China | News | 0 Comment | 05 Nov, 2024
Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...Read more
Biosynth Biological Technology opens new state-of-the-art facility in China
China | News | 1 Comment | 31 Oct, 2024
Switzerland-headquartered Biosynth, a leading developer and supplier of critical raw materials and services for diagnost...Read more
Korean startup Neurophet secures significant foothold to accelerate entry into China market
China | News | 60 Comment | 31 Oct, 2024
South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has secured a s...Read more
Hong Kong Innovation Center opens to provide one-stop support for early-stage drug discovery
China | News | 1 Comment | 30 Oct, 2024
ATLATL Hong Kong Innovation Center, a new state-of-the-art research facility designed to provide immediate, move-in-read...Read more
China's WuXi Biologics launches WuXia RidGS for non-antibiotic cell line development
China | News | 2 Comment | 29 Oct, 2024
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...Read more
HELP Therapeutics Secures FDA Approval for Phase I Study of HiCM-188 in Heart Failure Treatment
China | News | 0 Comment | 22 Oct, 2024
HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...Read more
Hong Kong boosts biomedical industry by cultivating interdisciplinary medicine-engineering talent
China | News | 1 Comment | 18 Oct, 2024
The Hong Kong Polytechnic University (PolyU) and Sun Yat-sen University (SYSU) have signed a Memorandum of Understanding...Read more
Junshi Biosciences' oncology drug Toripalimab obtains marketing approval in India and Hong Kong SAR
China | News | 0 Comment | 16 Oct, 2024
Shanghai Junshi Biosciences Co. and its wholly-owned subsidiary, TopAlliance Biosciences Inc., has announced that toripa...Read more
Hong Kong to develop first one-stop acute stroke management model
China | News | 0 Comment | 15 Oct, 2024
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) and the Prince of Wales Hospital (P...Read more
China | News | 0 Comment | 14 Oct, 2024
Akeso Biopharma, headquarterd in Hong Kong, has successfully raised approximately $250 million through a share plac...Read more
China | News | 1 Comment | 10 Oct, 2024
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to...Read more
AstraZeneca inks billion dollar deal with China's CSPC Pharma to strengthen cardiovascular pipeline
China | News | 0 Comment | 07 Oct, 2024
British firm AstraZeneca has entered into an exclusive license agreement with China-based CSPC Pharmaceutical Group (CSP...Read more